Indeed, we found that the presence of LOF variants in TP53 correlated with SMAD4 loss of staining in the corresponding tumor tissue (as defined in the Materials and Method section, p = 0.008, Supplementary Table S8). Here, SMAD4 is linked to neoplasm.